4P-Pharma
Mathilde Mérot has a diverse work experience in the field of regulatory affairs. Mathilde is currently working as a Senior Manager Regulatory Affairs at POXEL since January 2022. Previously, they worked as a Regulatory Affairs Officer at Inventiva Pharma starting from October 2017. Before that, they were a Chef de projet réglementaire clinique at Hays, where they handled regulatory submissions for clinical trials and coordinated projects in various therapeutic areas. Mathilde also gained experience as a Stagiaire Evaluateur Coordinateur de Projet at ANSM Agence nationale de sécurité du médicament et des produits de santé and as a Regulatory Clinical Operation Manager at Merck. Mathilde has also worked at MSD France as a Lead Clinical Research Associate and at Servier as a Stagiaire Chef de projet clinique. Mathilde began their career as an Externe en Pharmacie at CHU de Dijon and worked as a Technicienne Essais Cliniques at CRO Isoclin.
Mathilde Mérot obtained a degree in Pharmacy from Faculté de Pharmacie Dijon, specializing in Industrie - Recherche clinique, from 2005 to 2011. Mathilde also completed a Master's degree in European and International Regulatory Affairs for Health Products at Faculté de Pharmacie de Lille from 2015 to 2016. Additionally, they received a Master's degree in Clinical Trials and Pharmaceutical Development from Faculté de Pharmacie Poitiers from 2010 to 2011.
This person is not in any teams
4P-Pharma
1 followers
4P-Pharma is a clinical stage biotech company founded in Lille in 2014. We focus on untreated serious diseases with high unmet medical needs, aiming to rapidly deliver effective, regenerated, first-in-class therapies. The company has developed a proprietary development engine to address the main pain points of traditional drug development: time, costs, and predictability to deliver optimized risk adjusted returns. We leverage assets with a short time to market, strong IP position, and regulatory opportunities (emergency use or conditional marketing authorizations) in blue-ocean markets.